What is the next step in managing a 65-year-old asymptomatic smoker with microhematuria and normal computed tomography (CT) and cystoscopy results?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Asymptomatic Microhematuria in a 65-Year-Old Smoker with Normal CT and Cystoscopy

The next step for a 65-year-old asymptomatic smoker man with microhematuria and normal CT and cystoscopy is to implement a surveillance protocol with repeat urinalysis, urine cytology, and blood pressure measurements at 6,12,24, and 36 months. 1, 2

Rationale for Surveillance

  • Patients with a negative initial evaluation for asymptomatic microhematuria still require follow-up as some eventually develop significant urologic disease 1
  • This is especially important in high-risk groups, including patients older than 40 years and those who use tobacco, as hematuria can precede the diagnosis of bladder cancer by many years 1, 3
  • The risk of life-threatening lesions in patients with a negative initial evaluation is low, but continued monitoring is necessary due to the patient's risk factors (age and smoking history) 1, 2

Recommended Surveillance Protocol

  • Repeat urinalysis at 6,12,24, and 36 months 1, 2
  • Include voided urine cytology at these intervals 1, 3
  • Monitor blood pressure at each follow-up visit 2
  • If hematuria persists for 3 years without any concerning developments, the patient does not require further urologic monitoring 1

Indications for Immediate Re-evaluation

  • Immediate urologic re-evaluation with consideration of cystoscopy, cytology, or repeat imaging is warranted if any of the following occur: 1, 2
    • Gross hematuria
    • Abnormal urinary cytology
    • Irritative voiding symptoms in the absence of infection

Additional Considerations

  • Consider nephrology referral if hematuria persists with development of hypertension, proteinuria, or evidence of glomerular bleeding (red cell casts, dysmorphic red blood cells) 1, 4
  • Research shows a low yield of repeat evaluation (1.2% for bladder cancer on repeat cystoscopy and 1.3% for suspicious renal masses on repeat imaging), but surveillance remains important due to the patient's risk factors 5
  • The combination of age >40 years and smoking history places this patient in a higher risk category, necessitating more vigilant follow-up 3, 4

Importance of Patient Education

  • Inform the patient about the importance of completing the full surveillance protocol, even if symptoms resolve 2
  • Emphasize the need to report any episodes of gross hematuria or new urinary symptoms immediately, as these require prompt re-evaluation 1, 2
  • Explain that smoking cessation would be beneficial to reduce the risk of developing urologic malignancies 3

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Evaluation of Hematuria in the Elderly

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Management of Hematuria in the Outpatient Setting

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Persistent Microscopic Hematuria

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.